> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Drug GMP Guide on Preventing Cross-Contamination
- URL: https://www.fdaweb.com/drug-gmp-guide-on-preventing-cross-contamination/
- Published: 2022-06-24T12:00:00.000Z
- Updated: 2026-09-14T17:49:56.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152159

*Federal Register* notice: FDA is making available a draft guidance entitled “Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination.” The document describes methods, facility design elements, and controls that are important in preventing drugs from being cross-contaminated with non-penicillin beta-lactam antibacterial drugs or non-antibacterial beta-lactam compounds, and it makes recommendations on how manufacturers can be compliant with GMP requirements for preventing cross-contamination. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-06-24/pdf/2022-13513.pdf?ref=fdaweb.com).